Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Journal of Oncology|April 24, 2020
Update on Pathophysiology, Treatment, and Complications of Carcinoid SyndromeDominique Clement, John Ramage, Raj SrirajaskanthanCancers|June 22, 2023
Optimising Outcomes and Surveillance Strategies of Rectal Neuroendocrine NeoplasmsRajaventhan Srirajaskanthan, Dominique Clement, Sarah Brown, et al.Current Oncology Reports|January 25, 2024
Sarcopenia and Neuroendocrine NeoplasmsDominique Clement, Sarah Brown, Monique V Leerdam, et al.Clinical Therapeutics|October 2, 2021
Weight Maintenance up to 48 Weeks in Patients With Carcinoid Syndrome Treated With Telotristat Ethyl: Pooled Data From the Open-Label Extensions of the Phase III Clinical Trials TELESTAR and TELECASTRajaventhan Srirajaskanthan, Marianne Pavel, Matthew Kulke, et al.Neuroendocrinology|June 1, 2025
Prognosis of NETs: Has There Been Improvement over the Last 30 Years?Dominique Clement, Debashis Sarker, Aviva Frydman, et al.Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|November 3, 2021
Nodal metastases in small rectal neuroendocrine tumoursSarah O'Neill, Amyn Haji, Suzanne Ryan, et al.Current Oncology Reports|June 13, 2024
Current Management of Neuroendocrine Tumour Liver MetastasesAditya Sharma, Mughilan Muralitharan, John Ramage, et al.Nuclear Medicine Communications|September 4, 2023
Improving outcomes in carcinoid heart disease - learning from a single centreJack Cope, Rory Maclean, Shweta Hota, et al.Gut|February 10, 2011
Evaluation of oesophageal mucosa integrity by the intraluminal impedance techniqueRicard Farré, Kathleen Blondeau, Dominique Clement, et al.European Journal of Nuclear Medicine and Molecular Imaging|April 7, 2022
Efficacy and safety of 177Lu‑DOTATATE in patients with advanced pancreatic neuroendocrine tumours: data from the NETTER-R international, retrospective studyDominique Clement, Shaunak Navalkissoor, Rajaventhan Srirajaskanthan, et al.Pageof 1